(Q36106811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Treatment with statins in the acute phase of ischemic stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

Joan Montaner

1 reference

12 August 2017

language of work or name

1 reference

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

211-221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

Rapid effects of statins: from prophylaxis to therapy for ischemic stroke

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Statins do more than just lower cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Low-density lipoprotein-independent effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

C-reactive protein and the future risk of thromboembolic stroke in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Collateral growth and angiogenesis around cortical stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Statins have biphasic effects on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Neuroprotective properties of statins in cerebral ischemia and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Effects of statins on endothelium and signaling mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces delayed neuronal death following transient forebrain ischemia in the adult rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Rising statin use and effect on ischemic stroke outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Favorable outcome of ischemic stroke in patients pretreated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Withdrawal of statin treatment abrogates stroke protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

Pravastatin Therapy and the Risk of Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.2.211

21 January 2018

Identifiers

DOI

10.1586/14737175.5.2.211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853491%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference